Regulator extends price cap on knee implants by one month till Sept 15

The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year

Pharma
In 2017, NPPA had capped the prices of cobalt chromium total knee implants at Rs 54,720.
BS Reporter
1 min read Last Updated : Aug 27 2020 | 5:45 PM IST
The National Pharmaceutical Pricing Authority (NPPA) has extended the price cap on knee implants by a month to September 15. The pricing regulator is meanwhile deliberating on the ceiling prices of the medical device. The price cap was valid till August 15.

The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year. The regulator had slashed prices of knee implants by almost 70 per cent around 2017 using the extraordinary powers granted under the Drug Price Control Order (DPCO), 2013.

Knee implants are devices used to replace parts of damaged knee joints in patients. In 2017, NPPA had capped the prices of cobalt chromium total knee implants at Rs 54,720.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :National Pharmaceutical Pricing AuthorityNPPAKnee implantshealthcare

Next Story